E-MTAB-566 - Transcription profiling by array of breast cancer samples treated and non-treated with celecoxib

Status
Released on 28 March 2013, last updated on 10 October 2013
Organism
Homo sapiens
Samples (74)
Array (1)
Protocols (4)
Description
Biopsies and surgical specimens were obtained from breast tumours treated and non-treated with celecoxib 400mg twice daily for 2 weeks
Experiment types
transcription profiling by array, compound treatment, in vivo
Contacts
Citation
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer. Brandao RD, Veeck J, Van de Vijver KK, Lindsey P, de Vries B, van Elssen CH, Blok MJ, Keymeulen K, Ayoubi T, Smeets HJ, Tjan-Heijnen VC, Hupperets PS. Breast Cancer Res 15(2):r29 (2013), Europe PMC 23566419
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-MTAB-566.idf.txt
Sample and data relationshipE-MTAB-566.sdrf.txt
Raw data (3)E-MTAB-566.raw.1.zip, E-MTAB-566.raw.2.zip, E-MTAB-566.raw.3.zip
Array designA-AFFY-44.adf.txt
Links